Kurma Partners
Pariskurmapartners.com
Overview
Kurma Partners is a European venture capital firm specializing in healthcare and biotechnology, focused on transforming scientific discoveries into medical solutions for severe diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TargED Biopharmaceuticals | Jun 2026 | Series A Extension | Lead |
| NUCLIDIUM AG | May 2026 | Series B Extension | Lead |
| Tacalyx | Apr 2026 | Seed | Co-investor |
| Laigo Bio | Mar 2026 | Seed | Lead |
| Alveus Therapeutics | Feb 2026 | Series A Extension | Co-investor |
Key People
Thierry Laugel
Managing Partner
Arnaud Pradier
Venture Partner
Dominique Poiroux
Venture Partner
Amanda Gett-Chaperot
Partner
Benjamin Belot
Partner - Investing In Healthtech, AI TechBio
Daniel Parera
Partner
Hadrien Bouchez
Partner
Philippe Peltier
Partner
Sylvain Cascarino
CFO - Partner
Séverine PENOT
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
